Table 2.

Characteristics of individual treatment arms where genotyping was performed (n = 175).

Characteristic	n (%)
Drug regimen
non-artemisinin monotherapy	68 (39%)
non-artemisinin combination therapy	29 (17%)
artemisinin monotherapy	6 (3%)
artemisinin combination therapy	72 (41%)
Total number of patients requiring genotyping *
1–9	42 (24%)
10–19	30 (17%)
20–49	54 (31%)
≥50	30 (17%)
no samples to genotype	8 (5%)
data not available	11 (6%)
Percent of samples successfully genotyped †
≤50%	14 (9%)
51% – 90%	46 (29%)
91% – 99%	25 (16%)
100%	71 (46%)
Percent of successfully genotyped samples classified as new infections
0%	20 (13%)
1% – 24%	25 (16%)
25% – 49%	33 (21%)
50% – 74%	41 (26%)
75% – 99%	24 (15%)
100%	12 (8%)

* Total number of patients who experienced recurrent malaria/parasitaemia excluding those patients whose recurrence occurred prior to the earliest day following therapy on which samples were collected for genotyping.

^† Samples not successfully genotyped include those for which genotyping was not attempted, for which genotyping failed to give a result, or for which genotyping gave indeterminate results.